Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell injection plus endoscopic dilation for Crohn’s disease strictures
2022-003833-21Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Jan 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of mesenchymal stem cells in Crohn's disease, sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Composite clinical and endoscopic/radiological response at week 48. Started Jan 2023; status: active.
02
Drugs
mesenchymal stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2022-003833-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003833-21.